US Patent 10973826 Antibody conjugates comprising toll-like receptor agonist
Patent 10973826 was granted and assigned to Novartis on April, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 25, 2016
0
Date of Patent
April 13, 2021
0
Patent Application Number
15333285
0
Patent Inventor Names
Tom Yao-Hsiang Wu
0
Xing Wang
0
Alex Cortez
0
Bernhard Hubert Geierstanger
0
Shailaja Kasibhatla
0
Tetsuo Uno
0
Timothy Z. Hoffman
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10973826 Antibody conjugates comprising toll-like receptor agonist
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.